GLIMPSE GROUP INC/THE (VRAR)

US37892C1062 - Common Stock

2.91  +1.32 (+83.02%)

Fundamental Rating

2

Overall VRAR gets a fundamental rating of 2 out of 10. We evaluated VRAR against 83 industry peers in the IT Services industry. While VRAR seems to be doing ok healthwise, there are quite some concerns on its profitability. VRAR has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

VRAR had negative earnings in the past year.
VRAR had a negative operating cash flow in the past year.
VRAR had negative earnings in each of the past 5 years.
VRAR had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of VRAR (-48.06%) is worse than 90.12% of its industry peers.
VRAR has a Return On Equity of -66.93%. This is in the lower half of the industry: VRAR underperforms 76.54% of its industry peers.
Industry RankSector Rank
ROA -48.06%
ROE -66.93%
ROIC N/A
ROA(3y)-58.09%
ROA(5y)-122.58%
ROE(3y)-110.23%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

VRAR's Gross Margin of 72.04% is amongst the best of the industry. VRAR outperforms 88.89% of its industry peers.
In the last couple of years the Gross Margin of VRAR has grown nicely.
VRAR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 72.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.13%
GM growth 5Y3.11%

4

2. Health

2.1 Basic Checks

VRAR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, VRAR has more shares outstanding
The number of shares outstanding for VRAR has been increased compared to 5 years ago.
VRAR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -2.56, we must say that VRAR is in the distress zone and has some risk of bankruptcy.
VRAR has a worse Altman-Z score (-2.56) than 88.89% of its industry peers.
There is no outstanding debt for VRAR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.56
ROIC/WACCN/A
WACC11.7%

2.3 Liquidity

A Current Ratio of 0.83 indicates that VRAR may have some problems paying its short term obligations.
VRAR's Current ratio of 0.83 is on the low side compared to the rest of the industry. VRAR is outperformed by 83.95% of its industry peers.
VRAR has a Quick Ratio of 0.83. This is a bad value and indicates that VRAR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.83, VRAR is not doing good in the industry: 83.95% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.83

3

3. Growth

3.1 Past

VRAR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 75.12%, which is quite impressive.
Looking at the last year, VRAR shows a very negative growth in Revenue. The Revenue has decreased by -35.59% in the last year.
Measured over the past years, VRAR shows a very strong growth in Revenue. The Revenue has been growing by 55.13% on average per year.
EPS 1Y (TTM)75.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.37%
Revenue 1Y (TTM)-35.59%
Revenue growth 3Y37.05%
Revenue growth 5Y55.13%
Sales Q2Q%-21.48%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y56.9%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year41.76%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VRAR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VRAR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

VRAR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GLIMPSE GROUP INC/THE

NASDAQ:VRAR (12/18/2024, 10:44:10 AM)

2.91

+1.32 (+83.02%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap52.87M
Analysts
Price Target
Short Float %
Short Ratio
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -48.06%
ROE -66.93%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 72.04%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.83
Quick Ratio 0.83
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)75.12%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y56.9%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-35.59%
Revenue growth 3Y37.05%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y